Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Monika Stetkova"'
Autor:
Georgios Valianatos, Barbora Valcikova, Katerina Growkova, Amandine Verlande, Jitka Mlcochova, Lenka Radova, Monika Stetkova, Michaela Vyhnakova, Ondrej Slaby, Stjepan Uldrijan
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185801 (2017)
MdmX overexpression contributes to the development of cancer by inhibiting tumor suppressor p53. A switch in the alternative splicing of MdmX transcript, leading to the inclusion of exon 6, has been identified as the primary mechanism responsible for
Externí odkaz:
https://doaj.org/article/388e2b6385c949e7a4f75a34a9d44a06
Autor:
Petr Fojtík, Martin Senfluk, Katerina Holomkova, Anton Salykin, Jana Gregorova, Pavel Smak, Ondrej Pes, Jan Raska, Monika Stetkova, Petr Skladal, Miroslava Sedlackova, Ales Hampl, Dasa Bohaciakova, Stjepan Uldrijan, Vladimir Rotrekl
Precise control of pluripotency is a requirement for the safe and effective use of hPSCs in research and therapies. Here we report that pyruvate dehydrogenase upregulates histone H3 pan acetylation and levels of pluripotency marker NANOG in 5% O2. Py
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8adb5538128ff5bb7537cc3c95326e87
https://doi.org/10.1101/2023.01.20.524871
https://doi.org/10.1101/2023.01.20.524871
Autor:
Monika Stetkova, Michaela Vyhnakova, Barbora Valčíková, Jitka Mlčochová, Amandine Verlande, Lenka Radová, Ondrej Slaby, Stjepan Uldrijan, Katerina Growkova, Georgios Valianatos
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 10, p e0185801 (2017)
PLoS ONE, Vol 12, Iss 10, p e0185801 (2017)
MdmX overexpression contributes to the development of cancer by inhibiting tumor suppressor p53. A switch in the alternative splicing of MdmX transcript, leading to the inclusion of exon 6, has been identified as the primary mechanism responsible for